Department of Obstetrics, Leiden University Medical Centre Leiden, Leiden, the Netherlands.
Department of Obstetrics and Gynaecology, Academic Medical Centre, Amsterdam, the Netherlands.
BJOG. 2018 Feb;125(3):375-383. doi: 10.1111/1471-0528.14706. Epub 2017 Aug 8.
To assess the costs of labour induction with oral misoprostol versus Foley catheter.
Economic evaluation alongside a randomised controlled trial.
Obstetric departments of six tertiary and 23 secondary care hospitals in the Netherlands.
Women with a viable term singleton pregnancy in cephalic presentation, intact membranes, an unfavourable cervix (Bishop score <6) without a previous caesarean section, were randomised for labour induction with oral misoprostol (n = 924) or Foley catheter (n = 921).
We performed economic analysis from a hospital perspective. We estimated direct medical costs associated with healthcare utilisation from randomisation until discharge. The robustness of our findings was evaluated in sensitivity analyses.
Mean costs and differences were calculated per women induced with oral misoprostol or Foley catheter.
Mean costs per woman in the oral misoprostol group and Foley catheter group were €4470 versus €4158, respectively [mean difference €312, 95% confidence interval (CI) -€508 to €1063]. Multiple sensitivity analyses did not change these conclusions. However, if cervical ripening for low-risk pregnancies in the Foley catheter group was carried out in an outpatient setting, with admittance to labour ward only at start of active labour, the difference would be €4470 versus €3489, respectively (mean difference €981, 95% CI €225-1817).
Oral misoprostol and Foley catheter generate comparable costs. Cervical ripening outside labour ward with a Foley catheter could potentially save almost €1000 per woman.
Oral misoprostol or Foley catheter for induction of labour generates comparable costs.
评估口服米索前列醇与 Foley 导管引产的成本。
随机对照试验的经济评估。
荷兰六所三级和 23 所二级保健医院的产科病房。
头位、胎膜完整、宫颈条件不佳(Bishop 评分<6)、无剖宫产史的足月单胎孕妇,随机分为口服米索前列醇(n=924)或 Foley 导管(n=921)引产组。
我们从医院角度进行经济分析。我们估计了从随机分组到出院与医疗保健利用相关的直接医疗费用。在敏感性分析中评估了我们研究结果的稳健性。
计算每位接受口服米索前列醇或 Foley 导管引产的女性的平均成本和差异。
口服米索前列醇组和 Foley 导管组每位女性的平均费用分别为€4470 欧元和€4158 欧元[平均差异€312,95%置信区间(CI)-€508 至€1063]。多项敏感性分析并未改变这些结论。然而,如果 Foley 导管组的低危妊娠宫颈成熟在门诊进行,仅在活跃分娩开始时入院产房,那么费用分别为€4470 欧元和€3489 欧元[平均差异€981,95%CI €225-1817]。
口服米索前列醇和 Foley 导管引产的成本相当。Foley 导管在产房外进行宫颈成熟可能会为每位女性节省近€1000 欧元。
口服米索前列醇或 Foley 导管引产的成本相当。